Verona Pharma(VRNA.US)

Last Updated 19:00:00 ET
longbridge loading

Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma | ACHV Stock News

StockTitan·
US
ACHV
+3.17%
US
VRNA
0.00%
US
FBT
+0.09%
StockTitan·
US
ACHV
+3.17%
US
VRNA
0.00%
US
FBT
+0.09%

Verana Health Transforms Site Selection and Patient Enrollment in Clinical Trials

Unusual Whales·
US
VRNA
0.00%
US
XBI
-0.29%
US
BIB
-0.18%
Unusual Whales·
US
VRNA
0.00%
US
XBI
-0.29%
US
BIB
-0.18%

New Verana Health AI Agent Boosts Efficiency and Compliance in MIPS Submissions

Unusual Whales·
US
NAVA
0.00%
US
VERA
-1.08%
US
VRNA
0.00%
Unusual Whales·
US
NAVA
0.00%
US
VERA
-1.08%
US
VRNA
0.00%

Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data | GH Stock News

StockTitan·
US
IDNA
-0.34%
US
VERA
-1.08%
US
BBH
-0.44%
StockTitan·
US
IDNA
-0.34%
US
VERA
-1.08%
US
BBH
-0.44%

13:00 ETArna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform

prnewswire·
US
SLRX
0.00%
US
BIB
-0.18%
US
SBIO
+0.33%
prnewswire·
US
SLRX
0.00%
US
BIB
-0.18%
US
SBIO
+0.33%

Cantor Fitzgerald Reiterates "Overweight" Rating for Verona Pharma PLC American Depositary Share (NASDAQ:VRNA)

Market Beat·
US
VRNA
0.00%
Market Beat·
US
VRNA
0.00%

Cantor Fitzgerald Remains a Buy on Verona Pharma (VRNA)

Tip Ranks·
US
VRNA
0.00%
Tip Ranks·
US
VRNA
0.00%

Verona Pharma Completes Acquisition and Delisting Process

Tip Ranks·
US
VRNA
0.00%
Tip Ranks·
US
VRNA
0.00%

Market news: Merck has completed the acquisition of Verona Pharma

Zhitong·
US
MRK
+1.60%
US
VRNA
0.00%
Zhitong·
US
MRK
+1.60%
US
VRNA
0.00%
© 2026 Longbridge｜Disclaimer